NCT06426823View on ClinicalTrials.gov

The Role of GIP in Postprandial Splanchnic Blood Flow Distribution and Metabolism in Patients With Type 2 Diabetes

NARecruitingINTERVENTIONAL
Enrollment

10

Participants

Timeline

Start Date

November 1, 2023

Primary Completion Date

July 31, 2024

Study Completion Date

December 31, 2024

Conditions
Blood Flow
Interventions
OTHER

Saline / placebo

NaCl (9 mg/ml)

OTHER

GIPR antagonist / study tool

GIP(3-30)NH2

Trial Locations (1)

2200

RECRUITING

Rigshospitalet, Copenhagen

All Listed Sponsors
collaborator

Rigshospitalet, Denmark

OTHER

lead

University of Copenhagen

OTHER